Rotterdam, The Netherlands - IMCD Group (“IMCD” or “Company”), a leading international speciality chemicals-focused distributor, today announces its intention to proceed with an Initial Public Offering (the “IPO” or the “Offering”) on Euronext Amsterdam. The Offering will consist of newly issued shares (the “New Offer Shares”) and a secondary sale of existing shares (the "Existing Offer Shares" and together with the New Offer Shares, the "Offer Shares") held by its current shareholders. The listing is envisaged to take place in the coming months, subject to market conditions.

Offering highlights

· Offering to consist of New Offer Shares in the amount of approximately € 270 million along with the sale of existing shares leading to a post-IPO free-float of between € 350 − € 500 million
· Proceeds of the primary offering of the New Offer Shares will be used to repay current debt and increase financial flexibility. Target leverage after listing of around 2.5x LTM EBITDA
· Offering to institutional and retail investors in the Netherlands and to certain institutional investors internationally

Company highlights

· Diversified and resilient business model and clear strategy for future profitable growth
· Strong track record outperforming market growth and playing a leading role as an industry consolidator through numerous successful acquisitions
· Marketing and sales-oriented approach combined with asset light business model enable IMCD to realise attractive conversion margins and cash generation
· Attractive investment proposition based on strong growth story with target annual dividend of 25 – 35% of adjusted net income

IMCD, a specialty chemicals-focused provider of marketing, sales and distribution services, employs over 1,400 people worldwide and is active in over 30 countries across Europe, Africa, Asia Pacific and in Brazil. Approximately 70% of IMCD’s employees are part of the specialised and experienced sales force, the vast majority of which has a technical or commercial background from a related industry. This sales force is a key asset, and critical to IMCD’s ability to maintain and expand its relationships with suppliers and customers. The Company has a diversified and resilient business model, operating in each of the life science end markets, including food and nutrition, pharmaceutical, and personal care, as well as the industrial end markets, including coatings, lubricants, plastics and rubber, and synthesis. It markets, sells and distributes a broad range of products, sourced from approximately 1,580 suppliers to approximately 27,000 customers.

Piet van der Slikke, IMCD’s CEO: “We see the intended IPO as a logical next step in the development of our Company. Since our establishment in 1995 we have been able to show significant growth. We have developed an international footprint through expanding our pan-European network and developing a strong emerging markets footprint. Our current main shareholder Bain Capital has supported us in our clear strategy for profitable growth, which we achieve through market growth, through expanding market share and through acquisitions. In the past three years we realised over 15 acquisitions and see many more exciting opportunities ahead.

Full access to both debt and equity capital markets will support the pursuit of these opportunities. I believe IMCD, as a market leader in a growing industry, is ideally suited to further build on its international growth strategy and we look forward to this next step in our development. We will continue to further build on our strengths and work hard to remain a trusted business partnerproviding industry-leading specialist products and services.”